Terms: = Breast cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Staging
18 results:
1. ASIC1a contributes to the epithelial-mesenchymal transformation of breast cancer by activating the Ca
Wang J; Yang C; Yu R; Zhuang M; Jiang F
Environ Toxicol; 2024 Feb; 39(2):991-1000. PubMed ID: 37994395
[TBL] [Abstract] [Full Text] [Related]
2. METTL3 Accelerates breast cancer Progression via Regulating EZH2 m
Hu S; Song Y; Zhou Y; Jiao Y; Li G
J Healthc Eng; 2022; 2022():5794422. PubMed ID: 35392146
[TBL] [Abstract] [Full Text] [Related]
3. Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (emt) based on contrast-enhanced ultrasound (CEUS).
Leng X; Huang G; Li S; Yao M; Ding J; Ma F
PLoS One; 2021; 16(12):e0261138. PubMed ID: 34932597
[TBL] [Abstract] [Full Text] [Related]
4. A Novel Immune and Stroma Related Prognostic Marker for Invasive breast cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract] [Full Text] [Related]
5. ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to promote malignant behaviors of colon adenocarcinoma.
Yao D; Bao Z; Qian X; Yang Y; Mao Z
Cell Biol Int; 2021 Oct; 45(10):2129-2139. PubMed ID: 34270850
[TBL] [Abstract] [Full Text] [Related]
6. Low Expression of Rasal2 Promotes Non-small Cell Lung cancer Metastasis through Ras/ERK Pathway.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):992-998. PubMed ID: 34193694
[TBL] [Abstract] [Full Text] [Related]
7. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive breast Carcinoma That Modulates the Tumor Microenvironment.
Chen Y; Meng Z; Zhang L; Liu F
Front Immunol; 2021; 12():664845. PubMed ID: 33968066
[TBL] [Abstract] [Full Text] [Related]
8. Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature.
Emad A; Ray T; Jensen TW; Parat M; Natrajan R; Sinha S; Ray PS
Breast Cancer Res; 2020 Jul; 22(1):74. PubMed ID: 32641077
[TBL] [Abstract] [Full Text] [Related]
9. The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancer.
Tajbakhsh A; Pasdar A; Rezaee M; Fazeli M; Soleimanpour S; Hassanian SM; FarshchiyanYazdi Z; Younesi Rad T; Ferns GA; Avan A
J Cell Physiol; 2018 Aug; 233(8):5623-5641. PubMed ID: 29150934
[TBL] [Abstract] [Full Text] [Related]
10. Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic breast cancer.
Bredemeier M; Edimiris P; Mach P; Kubista M; Sjöback R; Rohlova E; Kolostova K; Hauch S; Aktas B; Tewes M; Kimmig R; Kasimir-Bauer S
Clin Chem; 2017 Oct; 63(10):1585-1593. PubMed ID: 28778937
[TBL] [Abstract] [Full Text] [Related]
11. Interface between breast cancer cells and the tumor microenvironment using platelet-rich plasma to promote tumor angiogenesis - influence of platelets and fibrin bundles on the behavior of breast tumor cells.
Andrade SS; Sumikawa JT; Castro ED; Batista FP; Paredes-Gamero E; Oliveira LC; Guerra IM; Peres GB; Cavalheiro RP; Juliano L; Nazário AP; Facina G; Tsai SM; Oliva ML; Girão MJ
Oncotarget; 2017 Mar; 8(10):16851-16874. PubMed ID: 28187434
[TBL] [Abstract] [Full Text] [Related]
12. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
[TBL] [Abstract] [Full Text] [Related]
13. WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways.
Ji J; Jia S; Jia Y; Ji K; Hargest R; Jiang WG
Br J Cancer; 2015 Sep; 113(6):921-33. PubMed ID: 26291058
[TBL] [Abstract] [Full Text] [Related]
14. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory breast cancer Cells.
Cohen EN; Gao H; Anfossi S; Mego M; Reddy NG; Debeb B; Giordano A; Tin S; Wu Q; Garza RJ; Cristofanilli M; Mani SA; Croix DA; Ueno NT; Woodward WA; Luthra R; Krishnamurthy S; Reuben JM
PLoS One; 2015; 10(7):e0132710. PubMed ID: 26207636
[TBL] [Abstract] [Full Text] [Related]
15. Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.
Ren C; Han C; Fu D; Wang D; Chen H; Chen Y; Shen M
Int J Cancer; 2016 Apr; 138(7):1586-600. PubMed ID: 26178386
[TBL] [Abstract] [Full Text] [Related]
16. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract] [Full Text] [Related]
17. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.
Aleskandarany MA; Negm OH; Green AR; Ahmed MA; Nolan CC; Tighe PJ; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2014 Jun; 145(2):339-48. PubMed ID: 24771047
[TBL] [Abstract] [Full Text] [Related]
18. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract] [Full Text] [Related]
